Suppr超能文献

在社区尸检队列中,路易体痴呆、帕金森病痴呆和阿尔茨海默病痴呆的纵向运动衰退。

Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.

机构信息

Cleo Roberts Center, Banner Sun Health Research Institute, Sun City, Arizona, USA.

Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.

出版信息

Alzheimers Dement. 2023 Oct;19(10):4377-4387. doi: 10.1002/alz.13357. Epub 2023 Jul 8.

Abstract

INTRODUCTION

We examined the progression of extrapyramidal symptoms and signs in autopsy-confirmed dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and Alzheimer's disease dementia (AD).

METHODS

Longitudinal data were obtained from Arizona Study of Aging and Neurodegenerative Disease, with PDD (n = 98), AD (n = 47) and DLB (n = 48) further sub-grouped as with or without parkinsonism (DLB+ and DLB-). Within-group Unified Parkinson's Disease Rating Scale (UPDRS) -II and UPDRS-III trajectories were analyzed using non-linear mixed effects models.

RESULTS

In DLB, 65.6% had parkinsonism. Baseline UPDRS-II and III scores (off-stage) were highest (P < 0.001) for PDD (mean ± SD 14.3 ± 7.8 and 27.4 ± 16.3), followed by DLB+ (6.0 ± 8.8 and 17.2 ± 17.1), DLB- (1.1 ± 1.3 and 3.3 ± 5.5) and AD (3.2 ± 6.1 and 8.2 ± 13.6). Compared to PDD, the DLB+ group had faster UPDRS-III progression over 8-years (Cohen's-d range 0.98 to 2.79, P < 0.001), driven by gait (P < 0.001) and limb bradykinesia (P = 0.02) subscales.

DISCUSSION

Motor deficits progress faster in DLB+ than PDD, providing insights about expected changes in motor function.

HIGHLIGHTS

Dementia with Lewy bodies has faster motor progression than Parkinson's disease dementia Linear and non-linear mixed modeling analysis of longitudinal data was utilized Findings have implications for clinical prognostication and trial design.

摘要

简介

我们研究了尸检确诊的路易体痴呆(DLB)、帕金森病痴呆(PDD)和阿尔茨海默病痴呆(AD)患者的锥体外系症状和体征的进展情况。

方法

我们从亚利桑那州衰老与神经退行性疾病研究中获得了纵向数据,其中 PDD(n=98)、AD(n=47)和 DLB(n=48)进一步分为有或无帕金森病(DLB+和 DLB-)。使用非线性混合效应模型分析组内统一帕金森病评定量表(UPDRS)-II 和 UPDRS-III 轨迹。

结果

在 DLB 中,65.6%的患者有帕金森病。PDD 的基线 UPDRS-II 和 UPDRS-III 评分(未用药阶段)最高(P<0.001)(平均值±标准差分别为 14.3±7.8 和 27.4±16.3),其次是 DLB+(6.0±8.8 和 17.2±17.1)、DLB-(1.1±1.3 和 3.3±5.5)和 AD(3.2±6.1 和 8.2±13.6)。与 PDD 相比,DLB+组在 8 年内 UPDRS-III 的进展速度更快(Cohen's-d 范围为 0.98 至 2.79,P<0.001),这主要由步态(P<0.001)和肢体运动迟缓(P=0.02)亚量表驱动。

讨论

与 PDD 相比,DLB+患者的运动缺陷进展更快,这为我们了解运动功能的预期变化提供了线索。

重点

路易体痴呆的运动进展比帕金森病痴呆更快 线性和非线性混合建模分析纵向数据 研究结果对临床预后和试验设计具有启示意义。

相似文献

引用本文的文献

2
A common outcome set for trials in dementia with Lewy bodies (DLB COS).路易体痴呆试验的通用结局集(DLB COS)。
Alzheimers Dement (N Y). 2025 Jul 11;11(3):e70134. doi: 10.1002/trc2.70134. eCollection 2025 Jul-Sep.
4
Neurodegeneration: 2024 update.神经退行性变:2024年更新
Free Neuropathol. 2024 Dec 9;5:31. doi: 10.17879/freeneuropathology-2024-5848. eCollection 2024 Jan.

本文引用的文献

8
Research criteria for the diagnosis of prodromal dementia with Lewy bodies.路易体痴呆前驱期诊断的研究标准。
Neurology. 2020 Apr 28;94(17):743-755. doi: 10.1212/WNL.0000000000009323. Epub 2020 Apr 2.
10
New evidence on the management of Lewy body dementia.关于路易体痴呆管理的新证据。
Lancet Neurol. 2020 Feb;19(2):157-169. doi: 10.1016/S1474-4422(19)30153-X. Epub 2019 Sep 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验